Rehab Revenue Fuels Humanoid R&D

Fourier is using rehab as the cash engine and humanoids as the learning engine. Rehab systems are already sold through long, consultative hospital deals, which gives Fourier revenue, clinical relationships, and real world experience with robots that touch and guide people. The GR line then turns that foundation into deployment data, interaction feedback, and reference sites that matter for selling care robots into hospitals, eldercare, and other human facing settings.

• The rehab side is a real operating business, not a demo program. Fourier sells multi device rehab setups through RehabHub, and has added clinical partnerships like Brooks Rehabilitation and Kurage, which creates both equipment revenue and institutional access for future care robotics expansion.
  1 sacra 3 fftai 5 fftai
• The humanoid side is aimed at proving safety and usefulness in places where robots interact closely with people. GR-3 was introduced in August 2025 as a care focused humanoid for eldercare, hospital, and public service settings, which makes each deployment a product test and a sales case study at the same time.
  1 sacra 4 prnewswire
• This is a different path from industrial humanoid companies like Figure. Figure is winning factory buyers with shift hours, parts moved, and plant rollouts, while Fourier is building evidence around touch, supervision, and care workflows. Sunday shows the other care path, using a simpler wheeled robot for home tasks instead of a full humanoid body.
  2 sacra 6 sacra 7 sacra

The next step is turning rehab credibility into a broader care robot category. If Fourier can keep placing humanoids inside hospitals, eldercare groups, and research centers, it can compound clinical trust, workflow data, and product refinement into a defensible position that pure industrial humanoid companies and cold start home robot companies will have a harder time matching.